CARIM - Cardiovascular Research Institute Maastricht
CARIM is one of the top institutes for translational cardiovascular research in Europe. It is among the world leaders in the fields of research into vascular and thrombotic disorders and atrial fibrillation, as well as translational heart failure research. It has also made important international contributions to molecular imaging in the cardiovascular field.
Cardiovascular scientists from around the world have joined CARIM because it values open communication, close cooperation, high ambitions, excellent facilities, and a critical learning environment.
Research
The research within CARIM is divided into three divisions. Each division consists of more interdisciplinary research programmes, each led by a Principal Investigator (PI). The PIs are responsible for the scientific progress of the programme, the mentoring of PhD students and post-docs, and the financials of the programme.
Education
CARIM combines high-level scientific research with high-level education of young researchers, and is therefore qualified as a research school by the Royal Netherlands Academy of Arts and Sciences (KNAW) and recognised as an international training site for Early Stage Researchers by the European Union.
CARIM offers a flexible and integrated education and training programme that suits individual ambitions of our students. The education programme consists of a specialization within the FHML master's programmes in Biomedical Sciences and Physician-Clinical Investigator (MSc/MD) and a contiguous PhD (doctoral) training programme.
Divisions
The three divisions within CARIM are:
- Blood
- Heart
- Vessels
Three Vidi grants for FHML researchers
Aurélie Carlier, Bart Spronck and Nicole Leibold receive a Vidi grant of up to 850,000 euros to further develop their lines of research.
From research to improvements in patient care: Translate2Clinic Fellowship
Four medical specialists translate fundamental research into improvements for patients.
Five Veni grants for FHML researchers
Within FHML, five researchers are awarded a Veni grant of up to 320,000 euros to further develop their research ideas.
The alarming rise of prediabetes – high time for prevention
Miranda Schram (CARIM, MHeNs) researches prediabetes, which precedes diabetes type 2.
Digital health: measuring your pulse on your phone
Dominik Linz (CARIM) talks about arrhythmias and the upcoming Pulse Day, for which he hopes to collect over a thousand digital pulses.
CARIM works in close cooperation with the Maastricht University Medical Center+ (MUMC+). MUMC+ is known both nationally and internationally for its focus on prevention and taking an integrated approach to health care: from prevention, promotion of good health, and basic care, to top-level clinical diagnostics and treatment. Patient safety is our top priority in all of our endeavours. MUMC+ is part of The Netherlands Federation of University Medical Centres.
